Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes.

Trial Profile

Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Cerebral infarction; Coronary disorders; Embolism and thrombosis
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms McLORDD
  • Most Recent Events

    • 23 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 16 Jun 2013 Planned End Date changed from 1 Mar 2013 to 30 May 2014 as reported by University Hospital Medical Information Network - Japan.
    • 16 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top